High Purity Nootropics Powder: Advanced GABA Receptor Modulator for Stuttering Relief
A pharmaceutical intermediate with potent GABA receptor modulating properties, offering hope for stuttering treatment.
Get a Quote & SampleProduct Core Value
Nootropics Powder CAS 133737-32-3
This advanced pharmaceutical intermediate is a specific gamma-aminobutyric acid receptor modulating drug designed to alleviate stuttering.
- Explore the potential of GABA receptor modulating drugs for stuttering, leveraging this high-purity powder for targeted research.
- Discover the benefits of nonbenzodiazepine GABA agonists as anxiolytic agents in pharmaceutical development.
- Understand the role of cyclopyrrolidone compounds in addressing speech impediments and related neurological conditions.
- Investigate the chemical properties and uses of this pharmaceutical chemical, a key intermediate for novel therapies.
Advantages Delivered
Exceptional Purity
Achieve reliable research outcomes with a purity exceeding 99%, crucial for pharmaceutical intermediate applications.
Targeted Therapeutic Action
Effectively modulate GABA(A) receptors, a key pathway for developing treatments for stuttering and anxiety disorders.
Versatile Application
Utilize this white powder, freely soluble in water, as a versatile component in various pharmaceutical research and formulation projects.
Key Applications
Stuttering Treatment Research
Investigate the efficacy of GABA receptor modulating drugs for stuttering with this high-grade pharmaceutical intermediate.
Anxiolytic Drug Development
Advance the development of novel anxiolytic agents by utilizing this nonbenzodiazepine GABA agonist.
Neuroscience Research
Explore the complex mechanisms of the central nervous system by studying this cyclopyrrolidone compound and its GABA(A) receptor agonist activity.
Custom Pharmaceutical Synthesis
Source a reliable pharmaceutical intermediate with high purity for custom synthesis projects in the pharmaceutical sector.